Navigation Links
Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer
Date:12/7/2008

nous thromboemolism at the end of six months of therapy.

A final objective included the reversal of the anticoagulant effect of idrabiotaparinux, as there are medically relevant instances, such as prior to surgery, when there is the need to reverse the effects of an anticoagulant. The reversal of the anticoagulant effect was measured after a 30-minute intravenous infusion of avidin (100 mg), a hen egg protein that binds with biotin to reverse the Factor Xa inhibiting activity of idrabiotaparinux. At the end of the initial six-month treatment with idrabiotaparinux, a subset of patients was re-randomized to receive avidin (those in the idrabiotaparinux arm) or placebo (those in both the idrabiotaparinux and idraparinux arms to preserve blinding). Avidin or placebo was infused between two and five hours after the last injection of idrabiotaparinux or idraparinux. Anti-Factor Xa activity was measured just prior to the infusion, just after the infusion, and then every day for five days to ensure that the reversibility remained unchanged.

The study found that there was less clinically relevant bleeding (5.2 percent versus 7.3 percent) and less major bleeding (0.8 percent versus 3.8 percent) in those treated with idrabiotaparinux as compared with idraparinux. Rates of recurrent venous thromboembolism (2.3 percent versus 3.2 percent) and fatal or non-fatal pulmonary embolism (1.6 percent versus 1.8 percent) were similar with both idrabiotaparinux and idraparinux.

Levels of Factor Xa activity were identical in both treatment groups throughout the six-month study. Of the 52 idrabiotaparinux patients re-randomized to receive avadin or placebo, 41 were analyzed for reversal of Factor Xa activity (23 received avidin and 18 received placebo). At the end of the 30- minute infusion of avidin, mean anti-Factor Xa activity was reduced by 77.8 percent and was sustained for at least five days as compared with 2.4 percent fo
'/>"/>

SOURCE American Society of Hematology
Copyright©2008 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
2. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
3. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
4. Researchers at Cleveland Clinic Identify Site of Dysfunction in HDL, Carrier of Good Cholesterol
5. Video: New Research Discovers Independent Brain Networks Control Human Walking
6. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
7. Cleveland Clinic Researchers Identify Mechanism Behind Platelet Function and Potentially Fatal Blood Clot Formation
8. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
9. Diabetes Research Institute Invention Promotes Growth of Stem Cells into Insulin-Producing Cells
10. Researchers Identify Virus Possibly Responsible for Declining Honeybee Population Using 454 Sequencing Technology from Roche
11. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... , May 22, 2013  Milliman, Inc., a premier ... of its 2013 Milliman Medical Index (MMI), which measures ... four receiving healthcare benefits through an employer-sponsored preferred provider ... typical family in 2013 is $22,030. ... prior year on a percentage basis was the lowest ...
(Date:5/22/2013)... May 22, 2013 Pomerantz Grossman ... claims on behalf of investors of Intuitive Surgical, Inc. ... ) (CUSIP: 46120E602) who purchased Intuitive Surgical common stock ... "Class Period"). Such investors are advised to contact ... or 888-476-6529, ext. 237. The investigation ...
(Date:5/22/2013)... Minn. , May 22, 2013 /PRNewswire/ ... the successful completion of its global Phase ... an internally developed program for the management ... proprietary formulation technology.  USL255 is specifically engineered ... fluctuations in topiramate blood levels observed with ...
Breaking Medicine Technology:Annual Healthcare Cost for a Typical American Family is $22,030 According to 2013 Milliman Medical Index 2SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Intuitive Surgical, Inc. - ISRG 2Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 2Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 3Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 4
...  ZHUHAI, China, Oct. 24, 2011 ... a leading global manufacturer of electronic medical devices ... worldwide technology licensing agreement and the launch of ...  new generation of modular patient monitors. The agreement ...
... Mont., Oct. 24, 2011 Bacterin International ... leader in the development of revolutionary bone graft material and ... at the Singular Research,s Sixth Annual ,Best of the Uncovereds, ... Boulevard Hotel in Los Angeles, California. Bacterin,s chairman ...
Cached Medicine Technology:Guangdong Biolight Meditech Co., Ltd. Announces the Launch of Its Modular Patient Monitors with Masimo rainbow SET Pulse CO-Oximetry Technology 2Guangdong Biolight Meditech Co., Ltd. Announces the Launch of Its Modular Patient Monitors with Masimo rainbow SET Pulse CO-Oximetry Technology 3Guangdong Biolight Meditech Co., Ltd. Announces the Launch of Its Modular Patient Monitors with Masimo rainbow SET Pulse CO-Oximetry Technology 4Guangdong Biolight Meditech Co., Ltd. Announces the Launch of Its Modular Patient Monitors with Masimo rainbow SET Pulse CO-Oximetry Technology 5Guangdong Biolight Meditech Co., Ltd. Announces the Launch of Its Modular Patient Monitors with Masimo rainbow SET Pulse CO-Oximetry Technology 6Bacterin to Present at Sixth Annual Singular Research 'Best of the Uncovereds' Conference on October 26, 2011 2
(Date:5/22/2013)... May 22 (HealthDay News) -- Over the next two ... States is expected to more than double, topping more ... The main factor driving the increase: an aging ... and the American Stroke Association, was published May 22 ... absolutely strain the health care system," Dr. Bruce Ovbiagele, ...
(Date:5/22/2013)... Award Presented at the 2013 Annual M&A ... http://bit.ly/13DkFfk , Merrill Corporation is pleased to ... of the Year” at the 7th M&A Advisor Turnaround ... in Palm Beach, Florida. , Merrill DataSite is ... solution that optimizes the due diligence process and offers ...
(Date:5/22/2013)... Hurricane preparation isn’t just about stocking up ... Amica Insurance is reminding everyone to review their ... , “An important part of hurricane preparedness is reviewing ... vice president at Amica Insurance. “The best time to ... a storm.” , Flood damage is not covered under ...
(Date:5/22/2013)... 2013 Finding trustworthy, loving child care is ... for their children. To help parents in their search, ... information about their nurturing programs, staff and much more. , ... spirit of Paty’s Daycare,” said Patricia “Auntie Paty” Sutton, founder ... you visit the new website, from the first time that ...
(Date:5/22/2013)... Milwaukee, WI (PRWEB) May 22, 2013 Unknown ... approaching their area at 30 mph. Minutes before it ... public of the nearing threat. This gave them time to ... Telcom & Data is proud to provide a product ... situation occurs. A Wheelock SAFEPATH® SP40S Emergency Evacuation System ...
Breaking Medicine News(10 mins):Health News:Cost of Treating Strokes in U.S. Could Soar to $180B Annually by 2030: Report 2Health News:Cost of Treating Strokes in U.S. Could Soar to $180B Annually by 2030: Report 3Health News:Merrill DataSite New Press Release: Merrill DataSite® Virtual Data Room Honored as “Information Management Product/Service of the Year” 2Health News:Merrill DataSite New Press Release: Merrill DataSite® Virtual Data Room Honored as “Information Management Product/Service of the Year” 3Health News:Reviewing Insurance Policies: a Key Part of Hurricane Preparations 2Health News:Paty’s Daycare Launches New Website to Connect with Parents in Need of Nurturing Child Care 2Health News:Telcom & Data Introduces Wheelock SAFEPATH® SP40S Emergency Evacuation System, An Effective Office Tool to Protect Employees from Severe Weather Threats 2
... number of air passengers arriving from Mexico, analysis shows, ... received the most airline passengers from Mexico this spring ... infection, new research says. , The finding confirms that ... disease may strike next could provide governments and public ...
... 29 CCA Industries, Inc. (NYSE Amex: CAW ... a $0.07 cash dividend payable to all shareholders of record ... consecutive dividend paid by the company. "In the meantime, ... to continue our consecutive dividend stream," stated David Edell, CEO. ...
... , , Orthopaedic surgeons provide safety tips for Fourth ... Fourth-of-July fireworks always draw a crowd but those ... used with care. This Independence Day, the American Academy ... spectacular celebrations but urges adults and children to exercise extreme caution ...
... , ... of the few surgeons in the Maryland specially trained to perform the latest minimally invasive ... ... Hungerford, M.D. has joined Mercy Medical Center as the 135-year-old downtown hospital,s ...
... often the victims of these falls, CDC says , ... than 47,000 elderly Americans are treated at hospital emergency ... canes, according to a federal government study released Monday. ... a day. , U.S. Centers for Disease Control and ...
... was the first effective treatment in the fight against malaria ... against this devastating disease. But the drug is associated with ... sickness and headaches to blindness, deafness and in rare cases ... Scientists at The University of Nottingham have made a discovery ...
Cached Medicine News:Health News:Air Traffic Patterns Predict Swine Flu Spread 2Health News:Air Traffic Patterns Predict Swine Flu Spread 3Health News:Fireworks Should Sparkle in the Sky 2Health News:Orthopedic Surgeon Dr. Marc W. Hungerford, a Leading Expert in Field of Avascular Necrosis, Now at Baltimore's Mercy Medical Center 2Health News:Orthopedic Surgeon Dr. Marc W. Hungerford, a Leading Expert in Field of Avascular Necrosis, Now at Baltimore's Mercy Medical Center 3Health News:47,000 Elderly Hurt in Walker, Cane Mishaps Each Year 2Health News:Breakthrough in combating the side effects of quinine 2
... channel platelet aggregation profiler combined with a ... with Microsoft WindowsTM, the PAP-4CD has real ... storage of test results, plus simplified data ... are available: chromogenic assays, von willebrand assay ...
Express Elyte Systems....
Iron / TIBC (Ferrozine). Storage temp: 2 - 8 C. Linearity: 0 - 500 ug/dl. Expected values: from TIBC 250 - 400 ug/dl, from Iron 40 - 160 ug/dl. Available with Calibrator and Number of test are 100....
For the quantitative determination of iron, total iron-binding capacity in human serum....
Medicine Products: